HB 1796, the Confidential Insurance Communications Protection Act, requires insurers to keep certain health insurance communications confidential for people who fear safety risks (like domestic violence survivors). It allows "protected individuals" to request alternative communication methods (e.g., separate mailing addresses or secure emails) without needing to prove abuse, and insurers must comply within 10 business days. Insurers cannot disclose these requests to policyholders or third parties, deny coverage for making such requests, or require policyholder authorization. Violations would be enforced under Pennsylvania’s Unfair Insurance Practices Act, with potential fines or corrective orders.
HB 1302, the Medical Debt Interest Act, caps the interest rate on unpaid medical bills at 6% for healthcare providers (like hospitals and doctors) and medical debt collectors in Pennsylvania. The bill prohibits charging more than 6% interest on medical debt and classifies violations as unfair business practices under existing consumer protection law, allowing individuals to seek court enforcement. It takes effect 60 days after enactment.
SB 371, the Medical Debt Collection Protection Act, protects low-income patients from aggressive medical debt collection practices. It requires health care providers to screen patients for insurance and financial assistance *before* billing them for emergency or necessary care, and prohibits collectors from placing liens on primary homes or reporting debts to credit bureaus. The law also mandates a 30-day notice to patients before pursuing permissible actions like lawsuits or wage garnishment, including information about complaint procedures. It directly affects uninsured patients and those with household incomes under 300% of the federal poverty level (qualified patients), imposing new duties on the Attorney General and Department of Health for enforcement. The bill is currently pending in the Health & Human Services committee.
This bill changes Pennsylvania's medical assistance rules for nursing home residents. It allows eligible individuals to keep more of their personal money by adjusting how personal needs costs (like toiletries or small purchases) are deducted from their benefits. The key provision modifies the deduction calculation so residents' own funds aren't reduced when covering these daily expenses. This directly affects nursing home residents qualifying for state medical assistance programs.
HB 704 creates a new Neurodegenerative Disease Research Program and a dedicated funding mechanism within the Department of Health to support research on conditions like Alzheimer's and Parkinson's. The bill directs the Department of Health to manage the program and administer the Neurodegenerative Disease Research Program Fund, which will provide grants for scientific studies. This legislation directly affects researchers, medical institutions, and patients seeking treatments for neurodegenerative diseases by establishing a formal structure for funding and coordinating research efforts. The bill passed the legislature in June 2025 and is now pending final action by the Governor.
SB 865 requires emergency departments in Pennsylvania hospitals to test patient urine samples for fentanyl, medetomidine, and xylazine when conducting drug screenings for diagnosis, provided such testing is available. It mandates reporting positive results (meeting department-set thresholds) to the Department of Health, with deidentified data used for awareness efforts. The bill also creates a new requirement for the Department of Drug and Alcohol Programs to develop educational materials about the dangers of human medetomidine use - highlighting its veterinary origins, health effects, and how to discuss risks with others. These provisions directly affect emergency departments, patients receiving screenings, and residents through public health education. The law takes effect 60 days after enactment.
HB 821 amends Pennsylvania's Human Services Code to require the Department of Human Services to add assisted living services and supplemental health care services to the Community HealthChoices Medicaid program within 60 days. This change directly affects licensed assisted living residences, allowing them to become certified as medical assistance providers for these services. The bill mandates that the department submit necessary documentation to the federal Centers for Medicare and Medicaid Services (CMS) to implement the expansion. The policy change will enable these facilities to participate in the state's Medicaid program for covered services. The bill takes effect 60 days after enactment.
HB 840 establishes the Targeted Industry Cluster Certificate Scholarship Program to provide financial assistance for Pennsylvania residents pursuing specific short-term education programs. The program, administered by the Pennsylvania Higher Education Assistance Agency, offers grants for eligible students enrolled in approved courses that take two to four years to complete, including nursing, public health, and community health bachelor's degrees. The Department of Education and Department of Labor and Industry will collaborate to identify workforce-focused programs and approve eligible educational providers. This bill directly affects students seeking credentials in high-demand fields and requires the agency to set grant awards based on available funding.
HB 1192 establishes a "Mothers Treatment Court Pilot Program" within Pennsylvania's minor courts, targeting mothers involved in the criminal justice system who require substance abuse or mental health treatment. The bill requires the Administrative Office of Pennsylvania Courts to create guidelines within six months for identifying eligible mothers, addressing their specific needs, and collecting data on program outcomes. Counties implementing the program must track participant referrals, charges, outcomes, and report annually - without personally identifiable information - to a public website. This pilot program, initially limited to minor courts, aims to provide court-supervised treatment alternatives rather than standard criminal penalties for qualifying mothers.
SB 269 amends Pennsylvania's 1965 Newborn Child Testing Act to add Duchenne muscular dystrophy to the list of conditions screened for in newborns. The bill requires healthcare providers to administer screening tests for this condition as part of the existing newborn screening program. This directly affects newborns in Pennsylvania and the healthcare facilities that conduct these screenings, aiming to identify the condition early to prevent disability or death. The change takes effect 60 days after enactment.
